Schroder Investment Management Group Has $77.06 Million Stake in ICU Medical, Inc. (NASDAQ:ICUI)

Schroder Investment Management Group reduced its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 15.8% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 499,765 shares of the medical instruments supplier's stock after selling 94,087 shares during the period. Schroder Investment Management Group owned approximately 2.04% of ICU Medical worth $77,064,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of the stock. Harvest Fund Management Co. Ltd acquired a new stake in shares of ICU Medical during the fourth quarter worth $33,000. Murphy & Mullick Capital Management Corp acquired a new stake in shares of ICU Medical in the 4th quarter valued at about $52,000. Point72 Hong Kong Ltd bought a new stake in shares of ICU Medical in the third quarter valued at about $72,000. Venturi Wealth Management LLC lifted its holdings in shares of ICU Medical by 64.0% in the fourth quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier's stock valued at $82,000 after purchasing an additional 206 shares in the last quarter. Finally, Smartleaf Asset Management LLC boosted its position in shares of ICU Medical by 166.8% during the fourth quarter. Smartleaf Asset Management LLC now owns 907 shares of the medical instruments supplier's stock worth $140,000 after buying an additional 567 shares during the period. Institutional investors own 96.10% of the company's stock.

Analysts Set New Price Targets

ICUI has been the topic of several research reports. StockNews.com upgraded ICU Medical from a "hold" rating to a "buy" rating in a research note on Friday. Raymond James set a $97.00 price objective on shares of ICU Medical in a report on Wednesday, March 12th. Finally, Jefferies Financial Group upgraded shares of ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 target price for the company in a report on Wednesday, December 11th. One equities research analyst has rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Buy" and an average target price of $168.67.

Remove Ads

ICU Medical Stock Down 1.6 %

ICUI stock traded down $2.25 during mid-day trading on Friday, reaching $139.32. The company had a trading volume of 597,700 shares, compared to its average volume of 265,684. The company has a market capitalization of $3.42 billion, a price-to-earnings ratio of -30.49 and a beta of 0.73. ICU Medical, Inc. has a 52 week low of $93.36 and a 52 week high of $196.26. The stock has a 50 day simple moving average of $151.64 and a two-hundred day simple moving average of $162.55. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.